Literature DB >> 26885537

Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.

Abdullah Sarkar, Kailash Prasad1, Bulat A Ziganshin, John A Elefteriades2.   

Abstract

Aortic disease has a high rate of morbidity and mortality, and there are no documented screening methods to date. Yet biochemical research does show a significant link between soluble receptor for advanced glycation end-products (sRAGE) protein and cardiovascular disease. Therefore, it can be hypothesized that sRAGE plasma levels may help differentiate patients with aortic disease from the general population, which this paper will review and present.

Entities:  

Keywords:  Aortic aneurysm; Aortic disease; Screening biomarker; sRAGE

Year:  2013        PMID： 26885537      PMCID： PMC4750919          DOI： 10.12945/j.aorta.2013.13-047

Source DB:  PubMed          Journal:  Aorta (Stamford)        ISSN： 2325-4637


  46 in total

1.  Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.

Authors:  Giuseppina Basta; Guido Lazzerini; Marika Massaro; Tommaso Simoncini; Piero Tanganelli; Caifeng Fu; Thomas Kislinger; David M Stern; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 2.  Current concepts in the pathogenesis of abdominal aortic aneurysm.

Authors:  Gorav Ailawadi; Jonathan L Eliason; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2003-09       Impact factor: 4.268

Review 3.  Cellular and molecular mechanisms of thoracic aortic aneurysms.

Authors:  Ismail El-Hamamsy; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

4.  Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

Authors:  Enzo Emanuele; Angela D'Angelo; Carmine Tomaino; Giuliano Binetti; Roberta Ghidoni; Pierluigi Politi; Livia Bernardi; Raffaele Maletta; Amalia C Bruni; Diego Geroldi
Journal:  Arch Neurol       Date:  2005-11

5.  Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

Authors:  Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Maria P Buzzi; Chiara Belvito; Mariaclara Cuccia; Diego Geroldi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

6.  RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

Authors:  Loredana G Bucciarelli; Thoralf Wendt; Wu Qu; Yan Lu; Evanthia Lalla; Ling Ling Rong; Mouza T Goova; Bernhard Moser; Thomas Kislinger; Daniel C Lee; Yogita Kashyap; David M Stern; Ann Marie Schmidt
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

7.  Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention.

Authors:  Erick D McNair; Calvin R Wells; A Mabood Qureshi; Rashpal Basran; Colin Pearce; Jason Orvold; Jacobus Devilliers; Kailash Prasad
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

8.  The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.

Authors:  Francesco Cipollone; Annalisa Iezzi; Maria Fazia; Mirco Zucchelli; Barbara Pini; Chiara Cuccurullo; Domenico De Cesare; Giovanni De Blasis; Raffaella Muraro; Roberto Bei; Francesco Chiarelli; Ann Marie Schmidt; Franco Cuccurullo; Andrea Mezzetti
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

9.  Calcium-regulated intramembrane proteolysis of the RAGE receptor.

Authors:  Arnaud Galichet; Mirjam Weibel; Claus W Heizmann
Journal:  Biochem Biophys Res Commun       Date:  2008-03-18       Impact factor: 3.575

10.  Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm.

Authors:  Fan Zhang; K Craig Kent; Dai Yamanouchi; Yan Zhang; Kaori Kato; Shirling Tsai; Roman Nowygrod; Ann Marie Schmidt; Bo Liu
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969
View more
  5 in total

1.  Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies.

Authors:  Emanuela Branchetti; Joseph E Bavaria; Juan B Grau; Richard E Shaw; Paolo Poggio; Eric K Lai; Nimesh D Desai; Joseph H Gorman; Robert C Gorman; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-14       Impact factor: 8.311

2.  Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.

Authors:  Kailash Prasad; Abdullah Sarkar; Mohammad A Zafar; Ahmed Shoker; Hamdi Ei Moselhi; Maryann Tranquilli; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2016-02-01

Review 3.  The Predictive Role of Plasma Biomarkers in the Evolution of Aortopathies Associated with Congenital Heart Malformations.

Authors:  Amalia Făgărășan; Maria Oana Săsăran
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

4.  The Association of Serum Thrombomodulin with Endothelial Injuring Factors in Abdominal Aortic Aneurysm.

Authors:  Magdalena Budzyń; Bogna Gryszczyńska; Wacław Majewski; Zbigniew Krasiński; Magdalena Paulina Kasprzak; Dorota Formanowicz; Krzysztof Wojciech Strzyżewski; Maria Iskra
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

5.  Calprotectin and Receptor for Advanced Glycation End Products as a Potential Biomarker in Abdominal Aortic Aneurysm.

Authors:  Willy Hauzer; Wojciech Witkiewicz; Jan Gnus
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.